|
US1001159A
(en)
|
1910-07-25 |
1911-08-22 |
Elizabeth Nielsen |
Skirt-gage.
|
|
GB1472257A
(en)
|
1973-09-10 |
1977-05-04 |
Christiaens Sa A |
Derivative of 4-hydroxy-5-azacoumarin
|
|
US4866182A
(en)
|
1988-02-18 |
1989-09-12 |
Merrell Dow Pharmaceuticals Inc. |
Cardiotonic alkanoyl and aroyl oxazolones
|
|
US5338740A
(en)
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
|
JP3795305B2
(ja)
|
1999-07-19 |
2006-07-12 |
田辺製薬株式会社 |
医薬組成物
|
|
UA74419C2
(uk)
|
2001-02-21 |
2005-12-15 |
Ен Пі Ес Фармасьютікалс, Інк. |
Заміщені піридини та їх застосування як антагоністів рецептору метаботропного глутамату
|
|
MXPA03006597A
(es)
|
2001-03-28 |
2004-10-15 |
Pfizer |
Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad.
|
|
US7399759B2
(en)
|
2001-09-03 |
2008-07-15 |
Takeda Pharmaceutical Company Limited |
1, 3-benzothiazinone derivatives and use thereof
|
|
JP2005162612A
(ja)
|
2002-01-09 |
2005-06-23 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
Ｎ−アルキルスルフォニル置換アミド誘導体
|
|
CN100486576C
(zh)
*
|
2002-02-14 |
2009-05-13 |
法玛西雅公司 |
作为p38map激酶调节剂的取代吡啶酮类
|
|
US20040147561A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
WO2005004818A2
(en)
|
2003-07-09 |
2005-01-20 |
Imclone Systems Incorporated |
Heterocyclic compounds and their use as anticancer agents
|
|
US20060004001A1
(en)
|
2004-02-27 |
2006-01-05 |
Merz Pharma Gmbh & Co., Kgaa |
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
|
|
PE20060285A1
(es)
*
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
ATE454372T1
(de)
|
2004-04-01 |
2010-01-15 |
Lilly Co Eli |
Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
|
|
WO2006002099A2
(en)
|
2004-06-18 |
2006-01-05 |
Millennium Pharmaceuticals, Inc. |
Factor xa inhibitors
|
|
EP1786790B1
(en)
|
2004-07-26 |
2009-06-03 |
Eli Lilly And Company |
Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
|
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
|
WO2006123165A2
(en)
*
|
2005-05-19 |
2006-11-23 |
Astex Therapeutics Limited |
Pyrimidine derivatives as hsp90 inhibitors
|
|
WO2007023242A1
(en)
|
2005-08-24 |
2007-03-01 |
Merz Pharma Gmbh & Co. Kgaa |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
|
EP1984353B1
(en)
|
2006-01-23 |
2015-12-30 |
Amgen, Inc |
Aurora kinase modulators and method of use
|
|
JP2007314516A
(ja)
|
2006-04-25 |
2007-12-06 |
Daiichi Sankyo Co Ltd |
２以上の置換基を有するベンゼン化合物を含有する医薬
|
|
BRPI0714793A2
(pt)
|
2006-08-03 |
2015-06-16 |
Tufts College |
Análogos de niacina não enrubecedores e método de uso dos mesmos.
|
|
US20090318389A1
(en)
|
2006-08-04 |
2009-12-24 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine-1 phosphate receptor
|
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
|
KR20090087019A
(ko)
|
2006-12-01 |
2009-08-14 |
노파르티스 아게 |
생리적 심비대의 촉진을 위한 단백질 티로신 포스파타제의 억제제
|
|
MX2009010122A
(es)
|
2007-03-28 |
2009-10-19 |
Neurosearch As |
Derivados de purinilo y su uso como moduladores del canal de potasio.
|
|
CN102026970B
(zh)
*
|
2007-11-21 |
2013-07-31 |
解码遗传Ehf公司 |
用于治疗肺部和心血管病症的联芳基pde4抑制剂
|
|
BRPI0907650A2
(pt)
|
2008-01-25 |
2015-07-21 |
Torrent Pharmaceuticals Ltd |
Composições farmacêuticas compreendendo degradadores de produtos finais de glicosilação avançada (ages) e drogas adjuvantes como drogas anti-hipertensivas, antidiabéticas e etc
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
JP2011523997A
(ja)
|
2008-05-30 |
2011-08-25 |
フォスター ホイーラー エナージア オサケ ユキチュア |
酸素燃焼によって動力を発生させるための方法及び装置
|
|
JP2011526917A
(ja)
|
2008-06-30 |
2011-10-20 |
サイレーン ファーマシューティカルズ， インコーポレイテッド |
オキシインドール化合物
|
|
JP5535931B2
(ja)
|
2008-10-27 |
2014-07-02 |
武田薬品工業株式会社 |
二環性化合物
|
|
AU2009311640B2
(en)
*
|
2008-11-04 |
2013-09-26 |
Anchor Therapeutics, Inc. |
APJ receptor compounds
|
|
CA2771026A1
(en)
|
2009-09-24 |
2011-03-31 |
F. Hoffmann-La Roche Ag |
Indole derivatives as crac modulators
|
|
CN102510864A
(zh)
|
2009-09-24 |
2012-06-20 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒杂环化合物
|
|
WO2011062955A2
(en)
|
2009-11-18 |
2011-05-26 |
University Of Massachusetts |
Compounds for modulating tlr2
|
|
CA2783801A1
(en)
|
2009-12-18 |
2011-06-23 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
|
CN102906074A
(zh)
|
2010-05-24 |
2013-01-30 |
东亚荣养株式会社 |
稠合咪唑衍生物
|
|
EP2619190B1
(en)
*
|
2010-09-24 |
2015-08-12 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|
|
WO2012074022A1
(ja)
|
2010-12-01 |
2012-06-07 |
旭硝子株式会社 |
イリジウムカチオン錯体および発光組成物
|
|
US20140057953A1
(en)
|
2011-03-03 |
2014-02-27 |
Rolf Hartmann |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
|
EP2697196A1
(en)
|
2011-04-13 |
2014-02-19 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
WO2012158844A1
(en)
|
2011-05-17 |
2012-11-22 |
Shionogi & Co., Ltd. |
Heterocyclic compounds
|
|
CN104169278B
(zh)
|
2011-12-23 |
2017-10-24 |
巴斯夫欧洲公司 |
防治无脊椎动物害虫的异噻唑啉化合物
|
|
US9399638B2
(en)
*
|
2012-05-02 |
2016-07-26 |
Lupin Limited |
Substituted pyridine compounds as CRAC modulators
|
|
WO2013167633A1
(en)
|
2012-05-09 |
2013-11-14 |
Basf Se |
Acrylamide compounds for combating invertebrate pests
|
|
US9359284B2
(en)
|
2012-06-08 |
2016-06-07 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Benzathine analogs
|
|
EP2866803A1
(en)
|
2012-07-02 |
2015-05-06 |
Max-Delbrück-Centrum für Molekulare Medizin Berlin-Buch |
Psoralen derivatives for preventing or treating heart failure or cardiac hypertrophy
|
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
CN104640846A
(zh)
*
|
2012-09-21 |
2015-05-20 |
赛诺菲 |
用作apj受体调节剂的苯并咪唑-羧酸酰胺衍生物
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
EP2972394A4
(en)
|
2013-03-15 |
2016-11-02 |
Sloan Kettering Inst Cancer |
HSP90-DESIGNING AND THERAPY
|
|
EP3027625B1
(en)
|
2013-07-31 |
2018-05-30 |
Merck Sharp & Dohme Corp. |
Spiro-fused derivatives of piperidine useful for the treatment of inter alia hypertension and acute or chronic heart failure
|
|
JP6199197B2
(ja)
|
2014-02-07 |
2017-09-20 |
花王株式会社 |
ポリオキシアルキレンアルキルエーテルカルボン酸塩の製造方法
|
|
JP2017071553A
(ja)
|
2014-02-25 |
2017-04-13 |
味の素株式会社 |
ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
|
|
MX2016012175A
(es)
|
2014-03-20 |
2017-01-19 |
Bayer Pharma AG |
Nuevos compuestos.
|
|
CA2950952C
(en)
|
2014-06-10 |
2023-01-10 |
Sanford-Burnham Medical Research Institute |
Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
|
|
NZ737004A
(en)
|
2015-05-20 |
2022-10-28 |
Amgen Inc |
Triazole agonists of the apj receptor
|
|
AR104884A1
(es)
|
2015-06-03 |
2017-08-23 |
Bristol Myers Squibb Co |
Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
MX376824B
(es)
|
2015-10-14 |
2025-03-07 |
Bristol Myers Squibb Co |
2,4-dihidroxi-nicotinamidas como agonistas del recepor de apelina (apj).
|
|
EP3380970B1
(en)
|
2015-11-24 |
2023-01-04 |
Sanford Burnham Prebys Medical Discovery Institute |
Novel azole derivatives as apelin receptor agonist
|
|
CN108473466B
(zh)
|
2015-12-04 |
2022-04-19 |
百时美施贵宝公司 |
爱帕琳肽受体激动剂及使用方法
|
|
WO2017100558A1
(en)
|
2015-12-09 |
2017-06-15 |
Research Triangle Institute |
Improved apelin receptor (apj) agonists and uses thereof
|
|
JP6948322B2
(ja)
|
2015-12-16 |
2021-10-13 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ａｐｊ受容体のａｐｊアゴニストとしてのヘテロアリールヒドロキシピリミジノン
|
|
AU2017238504B2
(en)
|
2016-03-24 |
2021-05-27 |
Bristol-Myers Squibb Company |
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
|
|
ES2844184T3
(es)
|
2016-06-14 |
2021-07-21 |
Bristol Myers Squibb Co |
4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ
|
|
EP3468956B1
(en)
|
2016-06-14 |
2021-03-03 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-ones as apj agonists
|
|
EP3526198B1
(en)
|
2016-10-14 |
2020-08-12 |
Bristol-Myers Squibb Company |
3-sulfonyl-5-aminopyridine-2,4-diol apj agonists
|